Schellack, Sophie Klara
Breidenbach, Clara
Kowalski, Christoph
Wedding, Ulrich
van Oorschot, Birgitt
Seufferlein, Thomas
Benz, Stefan
Schnell, Martin
Köninger, Jörg
Klein, Christina
Ockenga, Johann
Freitag, Björn
Wittel, Uwe A.
Wahba, Roger
Kim, Mia
Elhabash, Saleem
Piso, Pompiliu
Weyhe, Dirk
Bunse, Jörg
Riechmann, Maren
von Strauss, Marco
Petzoldt, Sebastian
Neumann, Philipp-Alexander
Kolb, Vanessa
Sibert, Nora Tabea
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
Article History
Received: 3 February 2025
Accepted: 24 March 2025
First Online: 31 March 2025
Declarations
:
: The study was advised and approved by the ethics committee of the Berlin Medical Association (Eth-19/18). All the patients gave written consent for their participation in the study.
: CK, NTS, CB, SKS are employees of the German Cancer Society (DKG). SB and TS are members of the Scientific Advisory Board of the DKG. TS is a Board Member of the DKG. VK is employee of ClarData and OnkoZert, the certifying body of the German Cancer Society. JB has received payments for a lecture by Coloplast; has received support for travel and accommodations from Intuitive Surgical and is part of the EsmAil Trial Advisory Board. JO has received a study grant from the Federal Joint Committee in Germany. DW received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events for the German Society for General and Visceral Surgery and Medtronic. PAN received grants or contracts from the German Cancer Association, for the German Research Foundation Project, the Albrecht Stuppler Clinician Scientist Fellowship, the Bavarian Research Foundation and B. Braun Foundation; received payments for lectures from Johnson&Johnson and Dr. Falk; received a travel grant for a congress from Johnson& Johnson (payment was made to the institution); was part of the Advisory Board Johnson&Johnson. All other authors have declared no conflicts of interest.